Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
October 12, 2021
0Patent Application Number
201704170
Date Filed
April 17, 2017
0Patent abstract
The present disclosure relates to a method of treating advanced renal cell carcinoma (RCC) in human patients who have received prior anti-angiogenic therapy using CABOMETYX, a kinase inhibitor.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.